Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIMTA in Pretreated Pancreatic Cancer
NCT00490373Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in pancreatic adenocarcinoma (PDAC), sponsored by Eli Lilly and Company. Started Oct 2003; status: completed.
02
Drugs
pemetrexed
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00490373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490373.